Published April 2009 | Version v1
Journal article

18F-fluoro-2-deoxy-D-glucose positron emission tomography imaging and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma

  • 1. Mayo Clinic, Rochester, Minnesota, USA (United States). Dept. of Radiology
  • 2. Mayo Clinic, Rochester, Minnesota, USA (United States). Division of Pulmonary and Critical Care Medicine
  • 3. Mayo Clinic, Rochester, Minnesota, USA (United States). Dept. of Pathology

Description

Full text: Malignant pleural mesothelioma (MPM) is the most common primary pleural tumor and its incidence is rising. Its diagnosis, staging and response assessment are challenging for imaging. Integrated positron emission tomography (PET)/CT increases the accuracy of overall staging in patients with mesothelioma and improves the selection of patients for curative surgical resection. It is particularly useful in identifying occult distant metastases. It may be used to predict prognosis and to assess the metabolic response to therapy.

Availability note (English)

Available in abstract form only, full text entered in this record

Additional details

Publishing Information

Journal Title
Journal of Medical Imaging and Radiation Oncology
Journal Volume
53
Journal Issue
2
Journal Page Range
p. 160-170
ISSN
1754-9477

Optional Information

Notes
46 refs., 05 figs., 03 tabs.